Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication-Reference-Cited by-同舟云学术

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication

Published:2017-04 Issue: Volume:18 Page:204-215
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Xu Huanbin,Andersson Anne-Marie,Ragonnaud Emeline,Boilesen Ditte,Tolver Anders,Jensen Benjamin Anderschou Holbech,Blanchard James L.,Nicosia Alfredo,Folgori Antonella,Colloca Stefano,Cortese Riccardo,Thomsen Allan Randrup,Christensen Jan Pravsgaard,Veazey Ronald S.,Holst Peter Johannes^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. Novel biopanning strategy to identify epitopes associated with vaccine protection;Bachler;J. Virol.,2013

2. HIV-1 vaccines. Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys;Barouch;Science,2015

3. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys;Barouch;Nature,2012

4. Use of recombinant adenovirus for metabolic engineering of mammalian cells;Becker;Methods Cell Biol.,1994

5. Optimal antigens for HIV vaccines based on CD8+ T response, protein length, and sequence variability;Betts;DNA Cell Biol.,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell control of SARS-CoV-2: When, which, and where?;Seminars in Immunology;2023-11

2. Recent SIV-Macaque Trials: A Reassessment of Immune Priming and Varying Infectability in Repeated Low-dose Challenge Studies;2021-07-29

3. The potential of adenoviral vaccine vectors with altered antigen presentation capabilities;Expert Review of Vaccines;2020-01-02

4. Mucosal Vaccines Against HIV/SIV Infection;Mucosal Vaccines;2020

5. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine;Journal of Translational Medicine;2019-05-24